每年出版 6 期
ISSN 打印: 1040-8401
ISSN 在线: 2162-6472
Indexed in
Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?
摘要
Chronic inflammation is one of the most evident and common pathological conditions leading to deregulated osteoclastogenesis and bone remodeling. Tumor necrosis factor (TNF) as a pleiotropic cytokine plays a key role, not only in inflammation, but also in bone erosion in diseases associated with bone loss. TNF can stimulate the proliferation of osteoclast precursors and, in most conditions, act together with other cytokines and growth factors such as receptor activator of nuclear factor (NF)-[kappa]B ligand (RANKL), interleukin-6, and transforming growth factor beta to synergistically promote osteoclast formation and bone resorption in vivo. A longstanding enigma in the field is why TNF alone is not able to induce osteoclast differentiation as effectively as the same superfamily member RANKL, a physiological master osteoclastogenic cytokine. Recent studies have highlighted several lines of evidence showing the intrinsic mechanisms through RBP-J, NF-[kappa]B p100/TNF receptor-associated factor 3, or interferon regulatory factor-8 that restrain TNF-induced osteoclast differentiation and bone resorption. These feedback inhibitory mechanisms driven by TNF shed light into the current paradigm of osteoclastogenesis and would provide novel therapeutic implications on controlling inflammatory bone resorption.
-
Goodman Stuart B., Gallo Jiri, Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment, Journal of Clinical Medicine, 8, 12, 2019. Crossref
-
Fintini Danilo, Cianfarani Stefano, Cofini Marta, Andreoletti Angela, Ubertini Grazia Maria, Cappa Marco, Manco Melania, The Bones of Children With Obesity, Frontiers in Endocrinology, 11, 2020. Crossref
-
Shiraishi Megumi, Fukuda Takeshi, Igarashi Takao, Tokashiki Tadashi, Kayama Reina, Ojiri Hiroya, Differentiating Rheumatoid and Psoriatic Arthritis of the Hand: Multimodality Imaging Characteristics, RadioGraphics, 40, 5, 2020. Crossref
-
Zhao Xingqi, Zhang Zhaohui, Wang Yiran, Qian Kai, Qin Hanjun, Wan Haoyang, Wang Shihao, Zhu Zhengwen, Yang Siqi, Jiang Nan, Zhang Yifang, Bai Yang, Deng Huimin, Yu Bin, Association of Antibiotic Alterations in Gut Microbiota With Decreased Osseointegration of an Intramedullary Nail in Mice With and Without Osteomyelitis, Frontiers in Endocrinology, 12, 2021. Crossref
-
Mao Yingji, Chen Yu, Fu Yingxiao, Guan Jingjing, Liang Mengxiang, Zhu Yansong, Yang Fugen, Li Feixiang, Zhang Zhe, Wan Chuanfeng, Zhou Pinghui, miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene, In Vitro Cellular & Developmental Biology - Animal, 56, 7, 2020. Crossref
-
Li Chang-hong, Ma Zhen-zhen, Jian Lei-lei, Wang Xin-yu, Sun Lin, Liu Xiang-yuan, Yao Zhong-qiang, Zhao Jin-xia, Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways, International Immunopharmacology, 90, 2021. Crossref
-
Machnicki Allison L., White Cassaundra A., Meadows Chad A., McCloud Darby, Evans Sarah, Thomas Dominic, Hurley John D., Crow Daniel, Chirchir Habiba, Serrat Maria A., Altered IGF-I activity and accelerated bone elongation in growth plates precede excess weight gain in a mouse model of juvenile obesity, Journal of Applied Physiology, 132, 2, 2022. Crossref
-
Dinesh Palani, Kalaiselvan Sowmiya, Sujitha Sali, Rasool Mahaboobkhan, miR‐506‐3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway, Journal of Cellular Physiology, 235, 12, 2020. Crossref
-
Xia Jia, Wan Yan, Wu Jiao-jiao, Yang Yu, Xu Jin-Feng, Zhang Li, Liu Dong, Chen Lu, Tang Fei, Ao Hui, Peng Cheng, Therapeutic potential of dietary flavonoid hyperoside against non-communicable diseases: targeting underlying properties of diseases, Critical Reviews in Food Science and Nutrition, 2022. Crossref